- All
- Important
- Financial Update
- Fund Raise
- Board Meeting
- Dividend/Bonus
- JV/Acquisition
- Investor Meet
- Insider Trade
- Pledging
- Others
Lupin Limited — Updates, 21-01-2026: Press Release
21-01-2026 | 07:51 am
21-01-2026 | 07:51 am
Lupin signed a licensing & supply deal with Galenicum for injectable Semaglutide across 23 countries. This partnership expands Lupin's leadership in global diabetes and obesity care, capitalizing on the growing GLP-1 market through commercialization and distribution.
No comments yet. Be the first to comment!